AbCellera Biologics Inc. (ABCL)
NASDAQ: ABCL · Real-Time Price · USD
3.030
-0.110 (-3.50%)
At close: Feb 21, 2025, 4:00 PM
3.070
+0.040 (1.32%)
After-hours: Feb 21, 2025, 7:56 PM EST
AbCellera Biologics Employees
AbCellera Biologics had 586 employees as of December 31, 2023. The number of employees increased by 91 or 18.38% compared to the previous year.
Employees
586
Change (1Y)
91
Growth (1Y)
18.38%
Revenue / Employee
$56,249
Profits / Employee
-$299,995
Market Cap
894.96M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 586 | 91 | 18.38% |
| Dec 31, 2022 | 495 | 109 | 28.24% |
| Dec 31, 2021 | 386 | 180 | 87.38% |
| Dec 31, 2020 | 206 | 99 | 92.52% |
| Dec 31, 2019 | 107 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 440,000 |
| Johnson & Johnson | 131,900 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 72,000 |
ABCL News
- 11 days ago - AbCellera to Participate at Upcoming Investor Conferences in March - Business Wire
- 4 weeks ago - AbCellera to Report Full Year 2024 Financial Results on February 27, 2025 - Business Wire
- 5 weeks ago - AbCellera Expands Collaboration with AbbVie to Develop Novel T-Cell Engagers for Oncology - Business Wire
- 2 months ago - AbCellera Biologics: Still A Concept Stock - Seeking Alpha
- 3 months ago - AbCellera to Present at Upcoming Investor Conferences in December and January - Business Wire
- 3 months ago - AbCellera Presents Data on Applications of T-Cell Engager Platform at SITC 2024 - Business Wire
- 3 months ago - AbCellera Biologics Inc. (ABCL) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 3 months ago - AbCellera Reports Q3 2024 Business Results - Business Wire